About Kyung Hee

Home > About Kyung Hee > Media & Press > News

News

Research

NO.291 11.07.2016

Precision & Regenerative Medicine to Tackle Cancer and Gerontological Diseases

 

Kyung Hee University is formerly launching the Biohealth Cluster and the rest of the five Connective Cooperation Clusters will soon follow

 

Kyung Hee is building five Connective Cooperation Clusters (Biotech and Health, Future Science, Civilization, Arts and Culture, and Social Physical Education) in response to the civilizational transformation and to equip future society with optimized educational institution and innovative research environment. Biohealth and Future Science clusters are currently making most progress. On October 18, 2016, the Biohealth cluster was officially launched with six focus projects. The Future Science cluster is also expected to launch shortly. The two clusters will introduce new convergence research, didactic, and executive programs along with new avenues of interdisciplinary research and commercialization of the knowledge outflowing.

 

 

Building new model of convergence encompassing Western Medicine, Korean Medicine, Life Science, Humanities, Management, and others
The Biohealth cluster is designed to take full advantage of Kyung Hee’s vast establishment on all areas of medicine, life science and healthcare, one of the best in the country, acquiring new knowledge and accelerating clinical implementation. The focus areas are precision medicine, regenerative medicine, oncology, gerontological disease, life health (medical equipment, functional food, cosmetics, natural pharmacology, etc.) and smart aging.

 

Precision medicine will create new biohealth knowledge based on multi-omics. Regenerative medicine will research various ways to restore organ functionality by regenerating human tissue cells or organ transplant. The current research focus is on human stem cell research.

 

Oncology will execute convergence study based on precision medicine and regenerative medicine. Kyung Hee University Humanitas Cancer Hospital that is set to open in 2018 will anchor all convergence cancer research activities and the clinical application of the knowledge discovered through integrated treatment programs tailored to individual patient.

 

 

Research capability of the entire University arrayed and focused on the cure of intractable health challenges
Prior to the official launch of the Biohealth cluster, Kyung Hee over the years has been building a blueprint for an ideal environment for convergence research that encompasses all disciplines of medicine (western medicine, Korean medicine, dentistry, pharmacology, nursing) as well as life science, humanities, management, and more. KHMC Medical Science Research Institute was first established in 2008 for convergence biohealth research, and in 2015 the Institute was reorganized as an overall governance hub that controls and coordinates all convergence research activities and clinical trials of Kyung Hee medical infrastructure in and out of the Seoul and Global Campuses. New discoveries made and knowledges gained herein will be expedited through clinical trials at Kyung Hee’s teaching hospitals to bring cure and health to patients suffering from intractable diseases and cancer. Kyung Hee University will continue to pour resources and recruit new talents into the Biohealth cluster to develop it into a world-class convergence medical science establishment.

 

 

Facebook 0
Twitter 0
Print

Return to News

News List

Highlight News